Alison Donald
University of Calgary(CA)NeuroDevelopment Center(US)Hotchkiss Brain Institute(CA)
Publications by Year
Research Areas
Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Respiratory Support and Mechanisms, Inhalation and Respiratory Drug Delivery, Meta-analysis and systematic reviews
Most-Cited Works
- → Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies(2015)74 cited
- → Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trials(2014)72 cited
- → CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial(2020)68 cited
- → Empirical assessment suggests that existing evidence could be used more fully in designing randomized controlled trials(2010)65 cited
- → An encouraging assessment of methods to inform priorities for updating systematic reviews(2008)29 cited
- → A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 µg on health-related quality of life in patients with COPD(2016)28 cited